Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

Does DOXORUBICIN Cause Hepatitis b dna increased? 17 Reports in FDA Database

Boost Your Natural Energy & Metabolism

Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.

Try Mitolyn Now

According to the FDA Adverse Event Reporting System (FAERS), 17 reports of Hepatitis b dna increased have been filed in association with DOXORUBICIN (Doxorubicin Hydrochloride). This represents 0.0% of all adverse event reports for DOXORUBICIN.

17
Reports of Hepatitis b dna increased with DOXORUBICIN
0.0%
of all DOXORUBICIN reports
1
Deaths
2
Hospitalizations

How Dangerous Is Hepatitis b dna increased From DOXORUBICIN?

Of the 17 reports, 1 (5.9%) resulted in death, 2 (11.8%) required hospitalization.

Is Hepatitis b dna increased Listed in the Official Label?

This adverse event is not currently listed in the official FDA drug label for DOXORUBICIN. However, 17 reports have been filed with the FAERS database.

What Other Side Effects Does DOXORUBICIN Cause?

Febrile neutropenia (8,844) Off label use (7,858) Disease progression (6,165) Neutropenia (5,891) Drug ineffective (4,598) Pyrexia (3,697) Thrombocytopenia (3,638) Anaemia (3,601) Product use in unapproved indication (3,502) Nausea (2,925)

What Other Drugs Cause Hepatitis b dna increased?

LAMIVUDINE (207) TENOFOVIR DISOPROXIL (120) ADEFOVIR DIPIVOXIL (83) ENTECAVIR (81) TENOFOVIR ALAFENAMIDE (31) RITUXIMAB (24) DEXAMETHASONE (20) CYCLOPHOSPHAMIDE (19) EMTRICITABINE\TENOFOVIR DISOPROXIL (19) LENALIDOMIDE (17)

Which DOXORUBICIN Alternatives Have Lower Hepatitis b dna increased Risk?

DOXORUBICIN vs DOXYCYCLINE DOXORUBICIN vs DOXYCYCLINE HYCLATE DOXORUBICIN vs DOXYCYCLINE\DOXYCYCLINE HYCLATE DOXORUBICIN vs DOXYLAMINE DOXORUBICIN vs DOXYLAMINE\PYRIDOXINE

Related Pages

DOXORUBICIN Full Profile All Hepatitis b dna increased Reports All Drugs Causing Hepatitis b dna increased DOXORUBICIN Demographics